Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposome Bupivacaine for Postoperative Pain After Craniotomy
NCT06701539Not yet recruiting
- Sponsor
- Beijing Tiantan Hospital
- Start
- Dec 2024
- Primary completion
- Jun 2025
- Modality
- Small Molecules
01
Overview
Randomised trial of bupivacaine in postoperative pain (2 arms), sponsored by Beijing Tiantan Hospital. Primary endpoint: Time of first incision pain within 72 hours after surgery. Planned start Dec 2024; status: not yet recruiting.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06701539.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06701539.